Thanks Jsmama
This is reassuring on two fronts. Firstly that VitroGrow production is not occurring at the maximum production rate so that capacity can increase prior to a need to invest in new productive capacity/techniques. Secondly that in the future there may not be as large a gap between incurring production costs and receiving sales revenue. The next 4C will be interesting.
